Business · 26/02/2013
FDA and DIA Host Seventh Annual Conference on Drug Statistics
The FDA and DIA are hosting a public conference to discuss statistical issues in drug development and review, with a focus on the FDA's Critical Path initiative.
Business · 26/02/2013
The FDA and DIA are hosting a public conference to discuss statistical issues in drug development and review, with a focus on the FDA's Critical Path initiative.
Explore insights